In a busy City week, Reckitt is set to declare a slowdown

Reckitt Benckiser, owner of Durex and Nurofen, kicks off a busy week in the City tomorrow, with interim results also due from FTSE 100 giants BP and GlaxoSmithKline.

Analysts at Credit Suisse expect Reckitt to show second-quarter year-on-year organic growth slowed by 1 per cent to 3 per cent on the first three months of the year. EasyJet will also announce third-quarter results.